The combination of dabrafenib/trametinib is approved for the treatment of pediatric glioma
For citations:
The combination of dabrafenib/trametinib is approved for the treatment of pediatric glioma. Pediatric pharmacology. 2023;20(2):176-177. (In Russ.)
Views:
298
Email this article 